Seeing Is Believing
Currently out of the existing stock ratings of Gavin Scott, 2 are a HOLD (100%).
Analyst Gavin Scott, carries an average stock price target met ratio of 100% that have a potential upside of 85.59% achieved within 50 days. Previously, Gavin Scott worked at JPMORGAN.
Gavin Scott’s has documented 4 price targets and ratings displayed on 1 stocks.
Most recent stock forecast was given on RXRX, Recursion Pharmaceuticals at 13-Nov-2023.
Analyst best performing recommendations are on RXRX (RECURSION PHARMACEUTICALS).
The best stock recommendation documented was for RXRX (RECURSION PHARMACEUTICALS) at 11/13/2023. The price target of $10 was fulfilled within 36 days with a profit of $4.17 (71.53%) receiving and performance score of 19.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-Mar-2023
$8
$3.97 (98.51%)
$8
13 days ago
(19-Oct-2026)
2/28 (7.14%)
$4.39 (121.61%)
71
Hold Since 18-Aug-2025
$5.5
$1.47 (36.48%)
$5
5 months 18 days ago
(14-May-2026)
1/3 (33.33%)
$2.46 (80.92%)
2
Hold Since 03-Sep-2024
$5.5
$1.98 (56.25%)
$5
5 months 19 days ago
(14-May-2026)
3/6 (50%)
$2.46 (80.92%)
65
Hold Since 26-Feb-2026
$6
$1.97 (48.88%)
$10
8 months 6 days ago
(26-Feb-2026)
2/3 (66.67%)
$2.23 (59.15%)
73
Hold Since 11-May-2021
$10
10 months 16 days ago
(17-Dec-2025)
2/2 (100%)
$4.17 (71.53%)
35